Quinidine and Venetoclax: Drug Interaction Guide

Quick answer: This is a major interaction — avoid combining Quinidine and Venetoclax unless specifically directed by your doctor.

Interaction severity: Major — avoid combination

How Quinidine interacts with Venetoclax

Quinidine inhibits P-glycoprotein and can inhibit CYP3A pathways relevant to venetoclax disposition. Increased venetoclax exposure raises the risk of severe neutropenia and tumor lysis syndrome.

What you should do

Avoid strong transporter or CYP3A inhibitors during venetoclax initiation and ramp-up when possible. If unavoidable, follow label-based venetoclax dose reduction and monitoring.

Key facts

Severity

Major — avoid combination

Mechanism

Quinidine inhibits P-glycoprotein and can inhibit CYP3A pathways relevant to venetoclax disposition. Increased venetocla...

Action

Avoid strong transporter or CYP3A inhibitors during venetoclax initiation and ramp-up when possible. If unavoidable, fol...

Important medical disclaimer: This page provides educational information about drug interactions for general reference. It is not a substitute for professional medical advice, diagnosis, or treatment. Always discuss your specific medications with a qualified healthcare provider before starting, stopping, or changing any treatment. About our editorial team.

Frequently asked questions

Can I take Quinidine and Venetoclax together?

No — this combination should generally be avoided. Avoid strong transporter or CYP3A inhibitors during venetoclax initiation and ramp-up when possible. If unavoidable, follow label-based venetoclax dose reduction and monitoring.

What is the severity of this interaction?

The interaction between Quinidine and Venetoclax is classified as Major — avoid combination. Quinidine inhibits P-glycoprotein and can inhibit CYP3A pathways relevant to venetoclax disposition. Increased venetoclax exposure raises the risk of severe neutropenia and tumor lysis syndrome.

What should I do if I'm prescribed both?

Avoid strong transporter or CYP3A inhibitors during venetoclax initiation and ramp-up when possible. If unavoidable, follow label-based venetoclax dose reduction and monitoring. Always consult your prescribing clinician — do not stop or change medications without medical guidance.

Last reviewed: by iMedic Medical Editorial Team. Our editorial process.